Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV was delisted on the 31st of July, 2023.
49 hedge funds and large institutions have $16.4M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 12 closing their positions.
949% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $99K
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
8% less funds holding
Funds holding: 53 → 49 (-4)
24% less capital invested
Capital invested by funds: $21.7M → $16.4M (-$5.27M)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$179K |
| 2 |
WG
Winton Group
London,
United Kingdom
|
+$178K |
| 3 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
+$84.1K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$74.5K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$1.34M |
| 2 |
CCFM
Clear Creek Financial Management
Silverdale,
Washington
|
-$195K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$150K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$123K |
| 5 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
-$103K |
NBRV Hedge Fund Activity: Q3 2020 in Review
49 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q3 2020, worth a combined $16.4M — down 24% from $21.7M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of NBRV and 8 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 12 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $179K. The largest seller was OrbiMed, cutting an estimated $1.34M.
- 49 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q3 2020, down from 53 in Q2 2020.
- Funds reported $16.4M of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q3 2020, down 24% quarter-over-quarter.
- 8 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q3 2020 and 12 closed out, a net change of -4 holders.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland buyer in Q3 2020 was Sabby Management, an estimated $179K added.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q3 2020 was OrbiMed, an estimated $1.34M sold.
Based on aggregated 13F filings for Q3 2020.